{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:50:48Z","timestamp":1776390648082,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007253","name":"Nancy Taylor Foundation for Chronic Disease","doi-asserted-by":"publisher","award":["3205042008"],"award-info":[{"award-number":["3205042008"]}],"id":[{"id":"10.13039\/100007253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007253","name":"Nancy Taylor Foundation for Chronic Disease","doi-asserted-by":"publisher","award":["3205042008"],"award-info":[{"award-number":["3205042008"]}],"id":[{"id":"10.13039\/100007253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03783-0","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:34:40Z","timestamp":1772872480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-2645","authenticated-orcid":false,"given":"Megan M.","family":"Simonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Al-Jaberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AnneMarie C.","family":"Brescia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"2","key":"3783_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"1","key":"3783_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12969-021-00522-4","volume":"19","author":"A Raab","year":"2021","unstructured":"Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F, et al. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry. Pediatr Rheumatol Online J. 2021;19(1):41.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"3783_CR3","first-page":"386","volume":"30","author":"B Flato","year":"2003","unstructured":"Flato B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol. 2003;30(2):386\u201393.","journal-title":"J Rheumatol"},{"issue":"1","key":"3783_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13075-024-03343-4","volume":"26","author":"H Qian","year":"2024","unstructured":"Qian H, Deng C, Chen S, Zhang X, He Y, Lan J, et al. Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis. Arthritis Res Therapy. 2024;26(1):103.","journal-title":"Arthritis Res Therapy"},{"key":"3783_CR5","unstructured":"Zhang F, Jonsson AH, Nathan A, Wei K, Millard N, Xiao Q et al. Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis. bioRxiv. 2022:2022.02.25.481990."},{"issue":"7","key":"3783_CR6","first-page":"351","volume":"16","author":"J McHugh","year":"2020","unstructured":"McHugh J. Targeting FLS signalling in RA. Nat Rev Rheumatol. 2020;16(7):351.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"3783_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3260","volume":"19","author":"G Schett","year":"2013","unstructured":"Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF. How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat Med. 2013;19(7):822\u20134.","journal-title":"Nat Med"},{"issue":"10055","key":"3783_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338.","journal-title":"Lancet"},{"issue":"2","key":"3783_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","volume":"44","author":"F Matcham","year":"2014","unstructured":"Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):123\u201330.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3783_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5312\/wjo.v5.i4.516","volume":"5","author":"L Magyari","year":"2014","unstructured":"Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, et al. Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World J Orthop. 2014;5(4):516\u201336.","journal-title":"World J Orthop"},{"issue":"6","key":"3783_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","volume":"13","author":"M Narazaki","year":"2017","unstructured":"Narazaki M, Tanaka T, Kishimoto T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol. 2017;13(6):535\u201351.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"3783_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","volume":"8","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8(8):959\u201370.","journal-title":"Immunotherapy"},{"issue":"1","key":"3783_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"2","key":"3783_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clim.2004.12.009","volume":"115","author":"A Mor","year":"2005","unstructured":"Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol. 2005;115(2):118\u201328.","journal-title":"Clin Immunol"},{"issue":"1","key":"3783_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13317-020-00145-x","volume":"12","author":"MJ Mousavi","year":"2021","unstructured":"Mousavi MJ, Karami J, Aslani S, Tahmasebi MN, Vaziri AS, Jamshidi A, et al. Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe. Autoimmun Highlights. 2021;12(1):3.","journal-title":"Autoimmun Highlights"},{"key":"3783_CR16","doi-asserted-by":"publisher","first-page":"1230293","DOI":"10.3389\/fphar.2023.1230293","volume":"14","author":"Y Tong","year":"2023","unstructured":"Tong Y, Li X, Deng Q, Shi J, Feng Y, Bai L. Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis. Front Pharmacol. 2023;14:1230293.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3783_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357.","journal-title":"Nat Immunol"},{"issue":"2","key":"3783_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14397595.2019.1574697","volume":"29","author":"S Akioka","year":"2019","unstructured":"Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol. 2019;29(2):275\u201386.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"3783_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/art.1780380209","volume":"38","author":"H Mangge","year":"1995","unstructured":"Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995;38(2):211\u201320.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3783_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12969-017-0217-6","volume":"16","author":"AC Brescia","year":"2018","unstructured":"Brescia AC, Simonds MM, McCahan SM, Sullivan KE, Rose CD. Prior to extension, Transcriptomes of fibroblast-like Synoviocytes from extended and Polyarticular juvenile idiopathic arthritis are indistinguishable. Pediatr Rheumatol Online J. 2018;16(1):3.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3783_CR21","doi-asserted-by":"crossref","unstructured":"Al-Jaberi L, Simonds MM, Brescia AC. CCL24, CXCL9, and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment. Rheumatology (Oxford). 2022.","DOI":"10.1093\/rheumatology\/keac617"},{"issue":"1","key":"3783_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40744-023-00628-z","volume":"11","author":"MM Simonds","year":"2024","unstructured":"Simonds MM, Freer ST, Al-Jaberi L, Brescia AC. Adalimumab Effectively Decreases Inflammation Downstream of TNF\u03b1 Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis. Rheumatol Ther. 2024;11(1):143\u201355.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"3783_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12969-023-00940-6","volume":"22","author":"MM Simonds","year":"2024","unstructured":"Simonds MM, Freer ST, Brescia AMC. Methotrexate inhibits BMP4 and abrogates the hypertrophic chondrocyte phenotype of synovial fibroblasts in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2024;22(1):6.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3783_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12969-020-00483-0","volume":"18","author":"MM Simonds","year":"2020","unstructured":"Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AC. Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation. Pediatr Rheumatol Online J. 2020;18(1):89.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3783_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12969-021-00556-8","volume":"19","author":"MM Simonds","year":"2021","unstructured":"Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AMC. The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes. Pediatr Rheumatol. 2021;19(1):72.","journal-title":"Pediatr Rheumatol"},{"key":"3783_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/prca.201600088","volume":"11","author":"AC Brescia","year":"2017","unstructured":"Brescia AC, Simonds MM, Sullivan KE, Rose CD. Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis. Proteom Clin Appl. 2017;11:5\u20136.","journal-title":"Proteom Clin Appl"},{"key":"3783_CR27","doi-asserted-by":"crossref","unstructured":"Characterizing and Displaying Multivariate Data. Methods of Multivariate Analysis2012. pp. 47\u201390.","DOI":"10.1002\/9781118391686.ch3"},{"key":"3783_CR28","unstructured":"Tabachnick BG, Fidell LS. Using Multivariate Statistics: Pearson Education; 2013."},{"issue":"5","key":"3783_CR29","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/art.38336","volume":"66","author":"AC Brescia","year":"2014","unstructured":"Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor beta signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor beta signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthritis Rheumatol. 2014;66(5):1352\u201362.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3783_CR30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI4304","volume":"103","author":"Y Kawaguchi","year":"1999","unstructured":"Kawaguchi Y, Hara M, Wright TM. Endogenous IL-1\u03b1 from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. J Clin Investig. 1999;103(9):1253\u201360.","journal-title":"J Clin Investig"},{"issue":"3","key":"3783_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s10753-022-01779-x","volume":"46","author":"G Wang","year":"2023","unstructured":"Wang G, Wang J, Li X, Wu Q, Yao R, Luo X. Hypoxia and TNF-\u03b1 Synergistically Induce Expression of IL-6 and IL-8 in Human Fibroblast-like Synoviocytes via Enhancing TAK1\/NF-\u03baB\/HIF-1\u03b1 Signaling. Inflammation. 2023;46(3):912\u201324.","journal-title":"Inflammation"},{"issue":"7","key":"3783_CR32","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1182\/blood.V90.7.2583","volume":"90","author":"F Liu","year":"1997","unstructured":"Liu F, Poursine-Laurent J, Wu HY, Link DC. Interleukin-6 and the Granulocyte Colony-Stimulating Factor Receptor Are Major Independent Regulators of Granulopoiesis In Vivo But Are Not Required for Lineage Commitment or Terminal Differentiation. Blood. 1997;90(7):2583\u201390.","journal-title":"Blood"},{"issue":"10","key":"3783_CR33","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.4049\/jimmunol.1600745","volume":"197","author":"YR Na","year":"2016","unstructured":"Na YR, Gu GJ, Jung D, Kim YW, Na J, Woo JS, et al. GM-CSF Induces Inflammatory Macrophages by Regulating Glycolysis and Lipid Metabolism. J Immunol. 2016;197(10):4101\u20139.","journal-title":"J Immunol"},{"issue":"D1","key":"3783_CR34","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2023","unstructured":"Agrawal A, Balc\u0131 H, Hanspers K, Coort SL, Martens M, Slenter DN, et al. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 2023;52(D1):D679\u201389.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3783_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41590-025-02137-3","volume":"26","author":"B Mishra","year":"2025","unstructured":"Mishra B, Bachu M, Yuan R, Wingert C, Chaudhary V, Brauner C, et al. IL-10 targets IRF transcription factors to suppress IFN and inflammatory response genes by epigenetic mechanisms. Nat Immunol. 2025;26(5):748\u201359.","journal-title":"Nat Immunol"},{"issue":"6","key":"3783_CR36","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.4049\/jimmunol.151.6.3337","volume":"151","author":"PM Villiger","year":"1993","unstructured":"Villiger PM, Kusari AB, ten Dijke P, Lotz M. IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes. J Immunol. 1993;151(6):3337\u201344.","journal-title":"J Immunol"},{"issue":"2","key":"3783_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5625\/lar.2018.34.2.80","volume":"34","author":"T Kuribayashi","year":"2018","unstructured":"Kuribayashi T. Elimination half-lives of interleukin-6 and cytokine-induced neutrophil chemoattractant-1 synthesized in response to inflammatory stimulation in rats. Lab Anim Res. 2018;34(2):80\u20133.","journal-title":"Lab Anim Res"},{"issue":"8","key":"3783_CR38","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/annrheumdis-2016-210511","volume":"76","author":"SJW Shoop-Worrall","year":"2017","unstructured":"Shoop-Worrall SJW, Verstappen SMM, Baildam E, Chieng A, Davidson J, Foster H, et al. How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition. Ann Rheum Dis. 2017;76(8):1381\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3783_CR39","doi-asserted-by":"publisher","first-page":"942417","DOI":"10.3389\/fimmu.2022.942417","volume":"13","author":"DE Mahmoud","year":"2022","unstructured":"Mahmoud DE, Kaabachi W, Sassi N, Tarhouni L, Rekik S, Jemmali S, et al. The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol. 2022;13:942417.","journal-title":"Front Immunol"},{"issue":"6","key":"3783_CR40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"3783_CR41","doi-asserted-by":"publisher","first-page":"709178","DOI":"10.3389\/fimmu.2021.709178","volume":"12","author":"L Cheng","year":"2021","unstructured":"Cheng L, Wang Y, Wu R, Ding T, Xue H, Gao C, et al. New Insights From Single-Cell Sequencing Data: Synovial Fibroblasts and Synovial Macrophages in Rheumatoid Arthritis. Front Immunol. 2021;12:709178.","journal-title":"Front Immunol"},{"issue":"11","key":"3783_CR42","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 1996;39(11):1781\u201390.","journal-title":"Arthritis Rheum"},{"key":"3783_CR43","doi-asserted-by":"crossref","unstructured":"Mahmoud DE, Kaabachi W, Sassi N, Tarhouni L, Rekik S, Jemmali S et al. The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.942417"},{"key":"3783_CR44","doi-asserted-by":"crossref","unstructured":"Micheroli R, Elhai M, Edalat S, Frank-Bertoncelj M, B\u00fcrki K, Ciurea A et al. Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis. RMD Open. 2022;8(1).","DOI":"10.1136\/rmdopen-2021-001949"},{"issue":"5","key":"3783_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1759720X10378372","volume":"2","author":"S Srirangan","year":"2010","unstructured":"Srirangan S, Choy EH. The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2010;2(5):247\u201356.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"3783_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-020-02369-8","volume":"22","author":"C Choi","year":"2020","unstructured":"Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, et al. Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):275.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3783_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40744-020-00219-2","volume":"7","author":"EG Favalli","year":"2020","unstructured":"Favalli EG. Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis. Rheumatol Therapy. 2020;7(3):473\u2013516.","journal-title":"Rheumatol Therapy"},{"key":"3783_CR48","doi-asserted-by":"publisher","first-page":"102304","DOI":"10.1016\/j.coph.2022.102304","volume":"67","author":"V Tsaltskan","year":"2022","unstructured":"Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022;67:102304.","journal-title":"Curr Opin Pharmacol"},{"issue":"10","key":"3783_CR49","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr2.11093","volume":"1","author":"D Hammaker","year":"2019","unstructured":"Hammaker D, Nygaard G, Kuhs A, Ai R, Boyle DL, Wang W, et al. Joint Location-Specific JAK-STAT Signaling in Rheumatoid Arthritis Fibroblast-like Synoviocytes. ACR Open Rheumatol. 2019;1(10):640\u20138.","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"3783_CR50","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.4049\/jimmunol.180.5.2989","volume":"180","author":"CN Tran","year":"2008","unstructured":"Tran CN, Thacker SG, Louie DM, Oliver J, White PT, Endres JL, et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol. 2008;180(5):2989\u201398.","journal-title":"J Immunol"},{"issue":"5","key":"3783_CR51","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","volume":"171","author":"CN Tran","year":"2007","unstructured":"Tran CN, Lundy SK, White PT, Endres JL, Motyl CD, Gupta R, et al. Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells. Am J Pathol. 2007;171(5):1588\u201398.","journal-title":"Am J Pathol"},{"issue":"4","key":"3783_CR52","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.4049\/jimmunol.166.4.2270","volume":"166","author":"Y Yamamura","year":"2001","unstructured":"Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J, et al. Effector function of resting T cells: activation of synovial fibroblasts. J Immunol. 2001;166(4):2270\u20135.","journal-title":"J Immunol"},{"issue":"1","key":"3783_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5114\/ceji.2014.42128","volume":"39","author":"J Szyma\u0144ska-Ka\u0142u\u017ca","year":"2014","unstructured":"Szyma\u0144ska-Ka\u0142u\u017ca J, Cebula-Obrzut B, Smolewski P, Stanczyk J, Smolewska E. Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment na\u00efve children with juvenile idiopathic arthritis. Cent Eur J Immunol. 2014;39(1):71\u20136.","journal-title":"Cent Eur J Immunol"},{"issue":"9","key":"3783_CR54","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/art.1780340912","volume":"34","author":"F de Benedetti","year":"1991","unstructured":"de Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991;34(9):1158\u201363.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3783_CR55","first-page":"493","volume":"10","author":"F De Benedetti","year":"1992","unstructured":"De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol. 1992;10(5):493\u20138.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03783-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:03:09Z","timestamp":1776387789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03783-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3783"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03783-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Synovial fluid was obtained from our Institutional Review Board-approved repository (IRB#84709). Patients who underwent clinically indicated arthrocentesis were offered inclusion into the repository and informed consent was obtained. Material Transfer and Data Use Agreements were established with Cincinnati Children\u2019s Hospital for use of their synovial fluid samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}